Analytical review of modern herbal medicines used in musculoskeletal system diseases

Authors

  • Анна Ігорівна Крюкова National University of Pharmacy Institute of Pharmacy Professionals Qualification Improvement 17 Vosstaniya sq., Kharkiv, Ukraine, 61001, Ukraine
  • Інна Миколаївна Владимирова National University of Pharmacy Institute of Pharmacy Professionals Qualification Improvement 17 Vosstaniya sq., Kharkiv, Ukraine, 61001, Ukraine

DOI:

https://doi.org/10.15587/2313-8416.2015.52001

Keywords:

musculoskeletal system diseases, review, nomenclature, pharmaceutical market, phytotheurapeutic remedies

Abstract

Effective and safe treatment of the musculoskeletal system diseases is one of the main branches of medicine in general and rheumatology in particular. The relevance of this problem is caused mainly by the high incidence in the population, and temporary and permanent work disability status development in patients. The duration of rheumatologic diseases necessitates the optimal regimen selection, providing effective treatment and helping to prevent potential side effects associated with long-term use of remedies.

Aim of research. The aim of our research was to perform an analytical review of modern herbal products registered in Ukraine and used for musculoskeletal system treatment. The drug analysis was made according to next parameters: producing country, manufacturer, dosage form, and the origin of remedies (natural or synthetic).

Methods. Conventional analytical studies of electronic and paper sources were used for realization of the given problem.

Results. As a result of the analytical review of modern herbal remedies registered in Ukraine and used for musculoskeletal system treatment, it was found that 20 trade names of drugs, more than 90% of which are homeopathic, are displayed on the pharmaceutical market. Concerning dosage forms, pills (38,5 %), injection solutions and oral drops (23,1 % and 11,5 %, respectively) gain the biggest market share.

Conclusion. It was found that imported drugs are widely available (80 %) on the analyzed market segment, while local remedies gain rather minor market share (about 20 %).

Among medicines of this group presented on Ukrainian market, imported homeopathic remedies gain the biggest share. Phytotheurapeutic drugs gain minor market share and have limited composition of natural active ingredients represented by the extracts of Harpagophytum procumbens, Apium graveolens, Salix alba, and Zingiber officinale

Author Biographies

Анна Ігорівна Крюкова, National University of Pharmacy Institute of Pharmacy Professionals Qualification Improvement 17 Vosstaniya sq., Kharkiv, Ukraine, 61001

Applicant

Department of Quality, Standardization and Certification of Medicines

Інна Миколаївна Владимирова, National University of Pharmacy Institute of Pharmacy Professionals Qualification Improvement 17 Vosstaniya sq., Kharkiv, Ukraine, 61001

Doctor of pharmaceutical sciences, associate professor

Department of Quality, Standardization and Certification of Medicines

References

Olynin ,A. Y. (2013). Hronicheskaya revmaticheskaya bol’. Osobennosti razviriya i principi lechenia [Chronic rheumatic pain. Features of development and principles of treatment]. Russion medical journal "Rheumatology", 6, 304–310.

Zupanets, I. A., Bezdetko, N. V., Usenko, V. A. (2002). Farmacevticheskaya opeka: Simptomaticheskoe lechenie systavnoj I mishechnoj boli [Pharmaceutical care: Symptomatic treatment of joint and muscle pain].Pharmacist, 12, 18–22.

State register of medicines of Ukraine. Available at: http://www.drlz.kiev.ua/

Listopad, A. Modern non-steroidal anti-inflammatory drugs on the pharmaceutical market of Ukraine. Available at: http://www.provisor.com.ua/archive/1999/N21/listopad.php

Fokina, N. M. (2013). NPVP: sistemnoe I local’noe primenenie (vibor specialistov) [nonsteroidal anti-inflammatory medications: systemic and local application (choice of professionals)] Russion medical journal "Rheumatology", 6, 320–322.

Legina, E. V. (2012). Hondroprotektori v lechenii octeoartroza [Chondroprotectors in the treatment of osteoarthritis]. Modern rheumatology, 2, 59–63.

Zagorіy, G. V., Dovzhuk, V. V. (2013). Doslidgennya medikamentoznogo zabezpechennya chvorih na revmatoidnij artrit [Research of medical support for the treatment of patients with rheumatoid arthritis in Ukraine]. Farmakom, 2, 56–60.

Fernandes, L., Hagen, K. B., Bijlsma, J. W. J., Andreassen, O., Christensen, P., Conaghan, P. G. et. al. (2013). EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Annals of the Rheumatic Diseases, 72 (7), 1125–1135. doi: 10.1136/annrheumdis-2012-202745

Shpichak, O. S., Tihonov, A. I. (2014). Marketingovie issledovania farmacevticheskogo rinka preparatov, ispolzyemih mestno pri zabolevaniah oporno-dvigatelnogo apparata [Marketing research pharmaceutical market of medications used topically for diseases of the musculoskeletal apparatus]. News of Farmacy, 1, 63–68.

Kovalenko, V. I. (Ed.) (2014). Kompendium 2014 – Lekarstvennie prepereti [Compendium-2014 – medications]. Kyiv: MORION, 2448.

Savustyanenko, A. V. (2014). Effectivnost’ ecstracta martini dyshistoj (Systamar) pri osteoartritah, poyasnichnoj boli i fibromialgii: obzor assledovanij[Efficacy of the extract Harpagophytum procumbens (Sustamar) for osteoarthritis, fibromyalgia and low back pain: a review of research]. Pain. Joints. Spine, 1 (13), 30–38.

Published

2015-10-30

Issue

Section

Pharmaceutical Sciences